Mass spectrometry-based proteomics reveals potential roles of NEK9 and MAP2K4 in resistance to PI3K inhibitors in triple negative breast cancers. (Q52374520)
Jump to navigation
Jump to search
scientific article published on 22 February 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mass spectrometry-based proteomics reveals potential roles of NEK9 and MAP2K4 in resistance to PI3K inhibitors in triple negative breast cancers. |
scientific article published on 22 February 2018 |
Statements
Mass Spectrometry-Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers (English)
Shunqiang Li
Filip Mundt
Sandeep Rajput
Arshag D Mooradian
Philipp Mertins
Michael A Gillette
Karsten Krug
Jeremy Hoog
Petra Erdmann-Gilmore
Tina Primeau
Shixia Huang
Dean P Edwards
Xiaowei Wang
Xuya Wang
Feng Gao
Gary L Johnson
Kuan-Lin Huang
Christopher J Yoon
Li Ding
David Fenyö
Matthew J Ellis
R Reid Townsend
Jason M Held
Steven A Carr
1 reference